Cargando…
Nanosized sustained-release pyridostigmine bromide microcapsules: process optimization and evaluation of characteristics
BACKGROUND: Pyridostigmine bromide (3-[[(dimethylamino)-carbonyl]oxy]-1-methylpyridinium bromide), a reversible inhibitor of cholinesterase, is given orally in tablet form, and a treatment schedule of multiple daily doses is recommended for adult patients. Nanotechnology was used in this study to de...
Autores principales: | Tan, Qunyou, Jiang, Rong, Xu, Meiling, Liu, Guodong, Li, Songlin, Zhang, Jingqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582480/ https://www.ncbi.nlm.nih.gov/pubmed/23459707 http://dx.doi.org/10.2147/IJN.S40860 |
Ejemplares similares
-
Effects of Cholinergic Stimulation with Pyridostigmine Bromide on Chronic Chagasic Cardiomyopathic Mice
por: de Cuba, Marília Beatriz, et al.
Publicado: (2014) -
Enhancement of Frequency Domain Indices of Heart Rate Variability by Cholinergic Stimulation with Pyridostigmine Bromide
por: Zarei, Ali Asghar, et al.
Publicado: (2011) -
Cholinergic Stimulation by Pyridostigmine Bromide Before Myocardial Infarction Prevent Cardiac and Autonomic Dysfunction
por: Barboza, C. A., et al.
Publicado: (2019) -
Pyridostigmine Bromide Pills and Pesticides Exposure as Risk Factors for Eye Disease in Gulf War Veterans
por: Truax, Lauren E., et al.
Publicado: (2023) -
Treatment of Dysphagia with Pyridostigmine Bromide in a Patient with the Pharyngeal-Cervical-Brachial Variant of Guillain-Barré Syndrome
por: Lee, Kwang Lae, et al.
Publicado: (2012)